Sanofi, Regeneron: Dupixent Recommended For EU Approval By CHMP To Treat COPD Patients
31/5 07:28
(RTTNews) - French drug major Sanofi (SNYNF, SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that Dupixent (dupilumab) has been recommended for European Union approval to treat patients with chronic obstructive pulmonary disease or COPD....